中国对关键药物成分的管制,有可能危及美国获得基本药物的机会,威胁国家安全。 China's control over key drug ingredients risks U.S. access to essential medicines, threatening national security.

一项新的研究警告说,中国在生产关键药物成分方面的主导作用威胁着美国获得基本药物的机会,由于供应链的脆弱性,给国家安全带来风险。 A new study warns that China's dominant role in producing key pharmaceutical ingredients threatens U.S. access to essential medicines, creating national security risks due to supply chain vulnerabilities. 专家们说,依赖外国制造业,特别是中国的外国制造业,可能会在全球危机期间扰乱药物供应,敦促增加国内生产和多样化来源,以确保抗御能力。 Experts say reliance on foreign manufacturing, especially from China, could disrupt drug availability during global crises, urging greater domestic production and diversified sourcing to ensure resilience.